Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Lightstone Closes $172M Fund for Early-Stage Biotechs 05/01/14 Boston
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
Catabasis Scores $32M Series B Round With IPO in Sight 11/15/13 Boston
Catabasis Pharmaceuticals Receives $32,400,000 Series B Financing 11/14/13 Boston
Catabasis Pharmaceuticals Lands $445,865 New Financing 06/27/13 Boston
East Coast Life Sciences Roundup: Jounce, Tokai, Lux, & More 02/15/13 National
Catabasis Passes First Trials With Anti-Inflammatory Drug 02/11/13 Boston
Catabasis Pharmaceuticals Garners $8,000,000 Series A Round 12/13/11 Boston
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News 10/21/11 Boston
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment 10/20/11 Boston
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond 09/15/10 National
VC Investment in New England Declines in Second Quarter (Two Out of Three Surveys Say); Top 10 Deals Dominated by Biotech 07/19/10 Boston
Oxford’s Fambrough Leaves for Dicerna, Clinical Data Aims to Take on Big Pharma with Antidepressants, Genzyme’s Termeer Courts Shareholders, & More Boston-Area Life Sciences News 05/14/10 Boston
New England Startups Collect $203M in April; Life Sciences and Internet Sectors Top the List 05/13/10 Boston
Genzyme Expects to Pay $175M to FDA, Westphal Leaves Sirtris to Run GSK Venture Arm, Gelesis Obesity Treatment Passes First Human Trial, & More Boston-Area Life Sciences News 04/23/10 Boston
Catabasis Pharmaceuticals Garners $39,600,000 Series A Funding Round 04/22/10 Boston
Catabasis, Led by Sirtris Vets, Seeks to Fight Diabetes by Controlling Inflammation 04/21/10 Boston
Oracle Acquires Phase Forward, Diax Collects Up to $12M from Paul Capital, Agios Gets $130M from Celgene, & More Boston-Area Deals News 04/21/10 Boston
Catabasis Pharmaceuticals Receives $39,600,000 Series A Funding 04/21/10 Boston
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News 04/16/10 Boston
Catabasis Pharmaceuticals Pockets $7.7M out of $40M Venture Round 04/15/10 Boston
Catabasis Pharmaceuticals Secures $7,700,000 New Financing 04/15/10 Boston
Page 1 of 1